공액리놀레산-트리글리세리드 78%

공액리놀레산-중성지방이란?

공액리놀레산 글리세라이드 (CLAG)는 글리세라이드 형태의 공액리놀레산 (CLA)이다.자연적으로 발생하는 CLAG은 우유나 쇠고기와 같은 반추 동물에서 흔히 발견된다.공액 리놀레산 글리세라이드 (CLAG)는 인체에 필수적인 기능성 지방산이지만, 인체 자체에서는 생성될 수 없다.Conjugated Linoleic Acid (CLA)의 제조에는 식물성 기름 (해바라기씨유, 땅콩기름 등)을 사용하는 경우가 많지만 홍화가 Conjugated Linoleic Acid glyceride (CLAG)의 함량이 가장 높거나 활성이 가장 강하기 때문에 가장 좋은 공급원은 홍화씨유 (한약재 홍화)이다.

공액 리놀레산 글리세라이드는 식품 등급의 홍화 씨 기름으로 만들어지며, 리놀레산이 공액 반응에 의해 공액 리놀레산으로 전환됩니다.그런 다음 공액 리놀레산 지방산은 식품 등급의 리파아제를 촉매로 사용하여 글리세롤과 에스테르화하여 공액 리놀레산 글리세라이드를 생성합니다.

그린 스프링 기술이 공급하는 공액 리놀레산 트리글리세라이드 78%는 투명한 연한 노란색의 유성 액체입니다.향과 맛이 부드럽고, 지방질이 뛰어나다.제품의 산가는 매우 낮고, 일반 지방에 비해 항산화 안정성이 더 좋습니다.연질캡슐을 만들어 소비할수 있으며 유제품, 식용유, 유화지방제품 등에 직접 널리 첨가할수도 있다.

Green Spring Technology는 우수한 R&D 팀, 전문 생산 팀, 숙련된 영업 팀을 통해 23년 동안 식물 추출물 생산을 전문으로 해왔습니다.Halal, Kosher, COSMOS, BRC, IFS, FDA, ISO 및 기타 많은 인증을 통과했습니다.그린스프링은 체계적인 품질 관리 시스템을 갖추고 있으며, 이를 엄격하게 이행하고 있으며, ISO, HACCP 등 품질 기준에 따라 생산을 체계화하고 있습니다.모든 제품은 추적이 가능하며, 원료부터 완제품까지 각 제품마다 상세한 테스트, 생산 보고서가 있어 생산 공정의 모든 링크를 제어하고 확인할 수 있습니다.권위 있는 타사 테스트 보고서를 사용할 수 있습니다.

규격: 

규정:

EU 규정에 부합한다.

Benefits:

Promotes Lipolysis and Metabolism

Studies have shown that Conjugated Linoleic Acid-Triglyceride increases the activity of carnitine palmitate transferase (the enzyme responsible for the hydrolysis of fats for release into the bloodstream) and decreases the activity of lipoprotein lipase (responsible for the absorption of fats). Conjugated Linoleic Acid Triglyceride helps with fat breakdown and protein synthesis, which is a boost for fat loss and muscle gain.

Seventeen clinical studies have demonstrated that Conjugated Linoleic Acid at doses ranging from 0.7 to 6.89 per day can reduce body fat by 3% to 9% and maintain lean muscle tissue. A 12-month trial showed that the Conjugated Linoleic Acid (CLA) powder consumption group averaged 8% less body fat than the placebo group in the same setting, while increasing muscle tissue by 0.6kg, compared to the placebo group, which did not experience these changes.

Inhibition of Cancer Cells

Since Pariza and other scholars discovered conjugated linoleic acid from ground beef in 1983 and studied its anti-mutagenic effect, many scholars at home and abroad have carried out extensive and in-depth research on the anti-cancer effect and mechanism of conjugated linoleic acid, which has provided a theoretical basis for human cancer prevention and treatment.

Numerous experiments in animal studies have shown that the inclusion of 0.1g Conjugated Linoleic Acid (CLA)/100g of dry matter in the diet of test animals significantly reduces tumourigenesis. It also protects against a wide range of cancers, including breast, skin, prostate, lung, colon, and stomach cancers.

Among the population-based studies on anti-tumour, a study in Finnish women showed a reduced risk of colon and breast cancer after supplementation with Conjugated Linoleic Acid Powder. In a further study of women with breast cancer, supplementation with 7.5g of Conjugated Linoleic Acid Powder per day for 10 weeks resulted in a significant reduction in Spot 14, a factor highly associated with breast cancer proliferation. It is suggested that Conjugated Linoleic Acid (CLA) may have some anti-tumour effects through immunomodulation.

Lipid Regulation and Anti-Atherosclerosis

Conjugated Linoleic Acid-Triglyceride improves dyslipidaemia and prevents atherosclerosis by reducing total cholesterol, triglycerides, LDL cholesterol and increasing HDL cholesterol.

One study found that supplementation of 0.7 to 1.4g Conjugated Linoleic Acid-Triglyceride per day in a subject population for 4 weeks resulted in a decrease in body fat content, serum triglycerides and serum total cholesterol. According to the results presented at the annual meeting of the American Chemical Society in August 2000, dietary supplementation of 6g Conjugated Linoleic Acid-Triglyceride per day for 8 weeks in patients with type 2 diabetes mellitus can reduce triglyceride levels and improve insulin secretion levels. This suggests that CLA may have a role in preventing secondary atherosclerosis in patients with type 2 diabetes.

Immunomodulation

Conjugated Linoleic Acid-Triglyceride modulates inflammatory factors by inducing lipid peroxidation for immunomodulation. Numerous experiments in animal studies have shown that CLA has the physiological effects of increasing antibody levels, normalizing immune organs, and promoting T-lymphocyte division in experimental animals.

Recent clinical findings have demonstrated that Conjugated Linoleic Acid-Triglyceride supplementation with 6g Conjugated Linoleic Acid-Triglycerideper day for 12 weeks in patients with rheumatoid arthritis reduces the production of pro-inflammatory factors such as TNF-α or nuclear factor k B (NFκB), reduces the symptoms of Crohn's disease, and improves quality of life. Supplementation of CLA and vitamin E in these rheumatoid arthritis patients significantly reduced arthritis markers such as citrullinated antibodies (CCP-A), matrix metalloproteinase 3 (MMP-3), and white blood cell counts.

Applications:

For Health Products:

Numerous scientific researches have proved that Conjugated Linoleic Acid-Triglyceride has a variety of important physiological functions such as anti-tumour, anti-oxidation, anti-atherosclerosis, improving immunity, improving bone density, preventing and controlling diabetes, etc.; and it can also reduce cholesterol as well as triglyceride and LDL cholesterol of animal and the human body, and it can reduce fat and increase muscle in animal and the human body. Conjugated Linoleic Acid-Triglyceride has been used as an additive in health products.